New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
10:23 EDTJNJ, EPB, FDO, FASTOptions with decreasing implied volatility: FDO JNJ FAST EPB
News For FDO;JNJ;FAST;EPB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 6, 2015
17:21 EDTFDOAdvance Auto Parts to replace Family Dollar in the S&P 500 as of July 8
Subscribe for More Information
12:43 EDTFDODollar Tree completes acquisition of Family Dollar
Subscribe for More Information
10:02 EDTJNJWi-LAN enters settlement, license agreement with Cordis
Subscribe for More Information
07:18 EDTFASTFastenal July volatility elevated at 31 into Q2 and outlook
Subscribe for More Information
July 2, 2015
16:53 EDTFDODollar Tree says receives FTC clearance to complete Family Dollar merger
Subscribe for More Information
July 1, 2015
16:53 EDTFDOFamily Dollar reports Q3 adjusted EPS 74c, consensus 82c
Subscribe for More Information
16:33 EDTJNJGilead submits NDA to FDA for single tablet regimen for HIV containing R/F/TAF
Gilead Sciences (GILD) announced that it has submitted a New Drug Application, or NDA, to the FDA for an investigational, once-daily single tablet regimen that combines Gileadís emtricitabine 200 mg and tenofovir alafenamide, or TAF, 25 mg with rilpivirine 25 mg, or R/F/TAF, from Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), for the treatment of HIV-1 infection in adult and pediatric patients 12 years of age and older. The data submitted in the NDA support the use of R/F/TAF among patients who are HIV treatment-naÔve or who are virologically suppressed and want to replace their current antiretroviral treatment regimen. A Priority Review voucher acquired from Knight Therapeutics in November 2014 was submitted to the FDA along with the R/F/TAF NDA. Under the Prescription Drug User Fee Act, or PDUFA, the anticipated target action date for the R/F/TAF NDA is six months after the FDAís acceptance of the filing. TAF is a novel, investigational nucleotide reverse transcriptase inhibitor, or NRTI, that has demonstrated high antiviral efficacy at a dose less than one-tenth that of Gileadís Viread, as well as improved renal and bone laboratory parameters as compared to TDF in clinical trials in combination with other antiretroviral agents. In addition to R/F/TAF, two other TAF-based HIV treatments are also under FDA review.
June 30, 2015
07:28 EDTFDODollar Tree shares poised to outperform, says Wells Fargo
Wells Fargo predicts that Dollar Tree will be re-ranked by quantitative investment models following its merger with Family Dollar (FDO), enabling Dollar Tree's stock to outperform. The firm predicts that Dollar Tree's P/E ratio will become much lower versus its peers after the merger closes. Wells keeps an Outperform rating on Dollar Tree.
June 25, 2015
09:21 EDTFDOFamily Dollar volatility low into Q1 and outlook
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use